/THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/TSX.V: COCOVANCOUVER, BC, June 4, 2026 /CNW/...
DOWNERS GROVE, Ill., June 4, 2026 /PRNewswire/ -- Univar Solutions, LLC ("Univar Solutions" or "the Company"), a leading global solutions provider to users of...
DOWNERS GROVE, Ill., June 4, 2026 /CNW/ -- Univar Solutions, LLC ("Univar Solutions" or "the Company"), a leading global solutions provider to users of...
Ethics Committee Approval Received for Pivotal Study Intended to Support U.S. FDA Class II Submission for QuickScan™ Strep AVANCOUVER, BC, June 4, 2026 /CNW/...
ARLINGTON, Va., June 4, 2026 /PRNewswire/ -- True Ground Housing Partners is proud to announce the Amazon Housing Fund as the 2026 Affordable Housing...
SAN FRANCISCO and SUZHOU, China, June 4, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and...
HILVERSUM, The Netherlands, June 4, 2026 /PRNewswire/ -- Universal Music Group N.V. ("UMG" or "the Company") today announced that it has repurchased 14,156,285 of its...
BRUSSELS, Belgium and CAMBRIDGE, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (Nasdaq: BIIB) today announced data, comprising two posters and three abstracts, at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress, demonstrating the clinical profile of dapirolizumab pegol (DZP), an investigational biologic in patients with systemic lupus erythematosus (SLE).
Best new products of 2025 and grocery industry innovators recognizedTORONTO, June 3, 2026 /CNW/ - Retail Council of Canada (RCC) proudly announces the winners...
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, June 3, 2026 /CNW/ - Principal Technologies Inc. (TSXV: PTEC) (FWB:...
CALGARY, Alberta, June 03, 2026 (GLOBE NEWSWIRE) -- PHX Energy" or the "Corporation") (TSX: PHX) announces that its Board of Directors (the "Board") has approved an increase to its 2026 capital expenditure program (the "Program") to $80 million, a $15 million increase from the previously announced Program.
VANCOUVER, British Columbia, June 03, 2026 (GLOBE NEWSWIRE) -- Diversified Royalty Corp. (TSX: DIV, DIV.DB.A and DIV.DB.B) (the “Corporation” or “DIV”) is pleased to announce that its board of directors has approved a cash dividend of $0.02375 per common share for the period of June 1, 2026 to June 30, 2026, which is equal to $0.285 per common share on an annualized basis. The dividend will be paid on June 30, 2026 to shareholders of record as of the close of business on June 15, 2026.